AMN / NEW DELHI
The National Pharmaceutical Pricing Authority under the Ministry of Chemicals and Fertilizers today put out the list of 390 anti-cancer non-scheduled medicines with Maximum Retail Price reduction up to 87 per cent. The revised prices have come into effect from today.
On 27th of last month, the Pricing Authority had put 42 anti-cancer drugs under 30 per cent Trade Margin cap.
Medicine manufacturers and hospitals have been directed to convey the revised rates. As many as 390 brands out of the 426 brands reported by manufacturers, showed downward price movement.
This move is expected to benefit 22 lakh cancer patients in the country and will result in annual savings of nearly 800 crore rupees to the consumers.